- Home
- MRK vs CXAIW Comparison
MRK vs CXAIW Comparison
Compare MRK & CXAIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRK
- CXAIW
- Stock Information
- Founded
- MRK 2000
- CXAIW N/A
- Country
- MRK United States
- CXAIW United States
- Employees
- MRK N/A
- CXAIW 41
- Industry
- MRK Biotechnology: Pharmaceutical Preparations
- CXAIW EDP Services
- Sector
- MRK Health Care
- CXAIW Technology
- Exchange
- MRK Nasdaq
- CXAIW Nasdaq
- Market Cap
- MRK 218.8B
- CXAIW N/A
- IPO Year
- MRK N/A
- CXAIW N/A
- Fundamental
- Price
- MRK $87.38
- CXAIW $0.12
- Analyst Decision
- MRK Buy
- CXAIW
- Analyst Count
- MRK 15
- CXAIW 0
- Target Price
- MRK $105.14
- CXAIW N/A
- AVG Volume (30 Days)
- MRK 13.0M
- CXAIW 20.9K
- Earning Date
- MRK 10-30-2025
- CXAIW 03-21-2025
- Dividend Yield
- MRK 3.82%
- CXAIW N/A
- EPS Growth
- MRK 20.41
- CXAIW N/A
- EPS
- MRK 6.49
- CXAIW N/A
- Revenue
- MRK $63,616,000,000.00
- CXAIW $7,200,000.00
- Revenue This Year
- MRK $1.84
- CXAIW N/A
- Revenue Next Year
- MRK $5.24
- CXAIW N/A
- P/E Ratio
- MRK $13.07
- CXAIW N/A
- Revenue Growth
- MRK 1.82
- CXAIW N/A
- 52 Week Low
- MRK $73.31
- CXAIW $0.11
- 52 Week High
- MRK $110.19
- CXAIW $0.14
- Technical
- Relative Strength Index (RSI)
- MRK 58.91
- CXAIW 60.17
- Support Level
- MRK $83.16
- CXAIW $0.08
- Resistance Level
- MRK $85.50
- CXAIW $0.12
- Average True Range (ATR)
- MRK 1.77
- CXAIW 0.02
- MACD
- MRK -0.02
- CXAIW 0.00
- Stochastic Oscillator
- MRK 53.62
- CXAIW 94.47
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
About CXAIW CXApp Inc. Warrant
CXApp Inc is a provider of AI-powered employee experience solutions, delivering enterprise-grade software that enhances workplace engagement, productivity, and operational efficiency. The company's flagship product, the CXAI Platform, provides a comprehensive suite of tools designed to empower employees and enable organizations to create smarter workplaces. The product's key components include CXAI Apps, CXAI BTS, and CXAI-VU. The company generates the majority of its revenue from Licenses.